期刊文献+

成人水痘46例临床分析 被引量:2

成人水痘46例临床分析
下载PDF
导出
摘要 目的探索更昔洛韦治成人水痘的疗效,与阿昔洛韦比较。方法将46例成人水痘随机分成2组:治疗组22例,用更昔洛韦10mg/kg,每日1次静滴,连用7d;对照组24例,用阿昔洛韦10mg/kg,每日1次静滴,连用7d。2组年龄为18~34岁,平均25~39岁。结果治疗组与对照组按照随机分组治疗1周后皮疹消失,体温逐渐降至正常,血常规正常,症状消失。治疗组发热持续时间短于对照组(P〈0.01),皮疹结痂时间早于对照组(P〈0.01)。结论更昔洛韦治疗成人水痘效果优于阿昔洛韦。 Objective To explore more to come WeiZhi adult the curative effect of los chicken pox, and acyclovir comparison. Methods 46 cases of adult chickenpox random into two groups: treatment group, 22 cases, with more to come in the wei los 10 mg/ kg, once per day, the static drops, 7 days gone; 24 cases of control group, with acyclovir 10 mg/kg, once per day, the static drops, Ed 7 days. Two groups of age 18 to 34 years old, an average of 25 to 39 years old. Results The treatment group and control group in random group therapy after a week rash resolved, the temperature gradually lower down to normal, and routine blood normal, symptoms disappear. The treatment group fever short duration in control group (P〈 0.01), skin rash scabby time early in the control group (P〈 0.01). Conclusion More to come in the wei los for adults chickenpox effect is better than acyelovir.
作者 王艳
出处 《中国卫生产业》 2012年第14期32-33,共2页 China Health Industry
关键词 成人 水痘 更昔洛韦 阿昔洛韦 Adult Chicken pox Ganeiclovir Acydorir
  • 相关文献

参考文献4

二级参考文献10

  • 1Faulds D, Heel RC. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections[ J ]. Drugs, 1990,39 (4) : 597 - 638.
  • 2Nevins TE, Dunn DL. Use of ganciclovir for cytomegalovirus infection[J ]. J Am Soc Nephrol, 1992,2( 12 suppl) : s270 - s273.
  • 3Elion GB, Furman PA, Fyfe JA, et al. The selectivity of action of an antiherpetic agent, 9- ( 2-hydroxyethoxymethyl ) guanine [ J ]. Rev Med Virol, 1999,9(3) : 147 - 152.
  • 4Steer CB, Szer J, Sasadeusz J, et al. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir[J ]. Bone Marrow Transplant, 2000,25 (6) : 657 - 664.
  • 5McGavin JK,Goa KL. Ganciclovir:an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients[J]. Drugs, 2001,61(8) : 1153-1183.
  • 6Velez G, Roy CE, Whiptcup SM, et al. High-dose intravitreal ganciclovir and foscarnet for cyto-megalovirus retinits[J]. Am J Ophthalmol,2001,131(3) :396 - 397
  • 7Frenkel LM, Capparelli EV, Dankner WM, et al. Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects, the pediatric AIDS chinical trial group [J ]. J Infect Dis, 2000, 182 ( 6 ):1016 - 1024
  • 8Mouly S, Aymard G, Diquet B, et al. Oral ganciclovir systemic exposure is enhanced in HIV-infected patients with diarrhea and weight loss[J].J Acquir Immune Defic Syndr,2000,24(4) :344 - 351
  • 9Dubrenil-Lemaire ML,Gori A, Vittecoq D, et al. Lenograstim for the treatment of neutropenia in patients receiving ganciclovir for Cytomegalovirus infection:a randomised, placebo-controlled trial in AIDS patients[J ]. Eur J Haematol, 2000,65 (5): 337 - 343
  • 10李春元.更昔洛韦的临床应用进展[J].国外医药(合成药.生化药.制剂分册),1998,19(3):172-175. 被引量:73

共引文献215

同被引文献3

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部